* Traders' bets for March rate cut drop below 50%

* ADM tumbles on CFO probe, profit forecast cut

* Indexes up: Dow 0.2%, S&P 500 0.2%, Nasdaq 0.3%

NEW YORK, Jan 22 (Reuters) - The S&P 500 rose to another record high on Monday as tech stocks added to recent gains and investors awaited upcoming corporate reports for clues on this year's profit outlook.

The S&P 500 hit an intraday high of 4,868.41 points. The benchmark confirmed a bull market on Friday after posting a record high close for the first time in two years.

Netflix, Tesla, Abbott Laboratories , Intel and Johnson & Johnson, are due to report this week.

Several top tech-related heavyweights, including Microsoft and Apple are expected to report results next week.

"The earnings and guidance are going to be crucial to continue underpin the mega tech force in the market," said Quincy Krosby, chief global strategist at LPL Financial in Charlotte, North Carolina.

An index of semiconductors was up 0.1% and hit a fresh all-time intraday high, while Nvidia was up 0.8%, also hitting a fresh record.

Also this week, investors await reports on the personal consumption expenditure (PCE) index, S&P Global PMI readings and an advance fourth-quarter GDP print to weigh the U.S. central bank's next policy decision when it meets on Jan. 31.

"It does make sense that the equity market is pretty confident here, just given the strength that we've seen so far in the first few weeks of the year on the back of the consumer," said Matt Stucky, chief portfolio manager for equities at Northwestern Mutual Wealth Management Company.

The Dow Jones Industrial Average rose 91.25 points, or 0.24%, to 37,955.05, the S&P 500 gained 9.15 points, or 0.19%, to 4,848.96 and the Nasdaq Composite added 41.97 points, or 0.27%, to 15,352.94.

Traders have sharply scaled back their expectations of an at least 25-basis-point rate cut first arriving in March, with focus now more on May with a 53% chance, according to the CME Group's FedWatch Tool.

Among the day's decliners, Archer-Daniels-Midland shares dropped 23% after placing its CFO on administrative leave for an investigation and cutting its full-year profit forecast.

Also, Gilead lost 10.2% after its cancer drug missed main goal in late-stage study.

Advancing issues outnumbered declining ones on the NYSE by a 2.74-to-1 ratio; on Nasdaq, a 2.13-to-1 ratio favored advancers.

The S&P 500 posted 80 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 152 new highs and 115 new lows.

(Additional reporting by Ankika Biswas and Johann M Cherian in Bengaluru and Sinead Carew in New York; Editing by Maju Samuel and Aurora Ellis)